Mcrpc Metastatic Castration Resistant Prostate Cancer clinical trials

Explore recruiting mcrpc metastatic castration resistant prostate cancer clinical trials.

Recruiting mcrpc metastatic castration resistant prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mcrpc Metastatic Castration Resistant Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(20510) A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of androgen receptor pathway inhibitor (ARPI) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of ARPI

Italy, Poland, Lithuania, Austria, Hungary, France +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Mcrpc Metastatic Castration Resistant Prostate Cancer trials by city

Mcrpc Metastatic Castration Resistant Prostate Cancer in Toronto Mcrpc Metastatic Castration Resistant Prostate Cancer in Vancouver Mcrpc Metastatic Castration Resistant Prostate Cancer in Montreal Mcrpc Metastatic Castration Resistant Prostate Cancer in Calgary Mcrpc Metastatic Castration Resistant Prostate Cancer in Edmonton Mcrpc Metastatic Castration Resistant Prostate Cancer in Ottawa Mcrpc Metastatic Castration Resistant Prostate Cancer in Winnipeg Mcrpc Metastatic Castration Resistant Prostate Cancer in Quebec City Mcrpc Metastatic Castration Resistant Prostate Cancer in Hamilton Mcrpc Metastatic Castration Resistant Prostate Cancer in Kitchener Mcrpc Metastatic Castration Resistant Prostate Cancer in London Mcrpc Metastatic Castration Resistant Prostate Cancer in Halifax Mcrpc Metastatic Castration Resistant Prostate Cancer in New York Mcrpc Metastatic Castration Resistant Prostate Cancer in Los Angeles Mcrpc Metastatic Castration Resistant Prostate Cancer in Chicago Mcrpc Metastatic Castration Resistant Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease